二元细菌细菌保护肠道粘膜屏障,并减轻非酒精性脂肪肝炎
1Department of Gastroenterology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Animal models and experimental medicine
|July 20, 2023
概括
双种Bacillus subtilis益生菌可以减少非酒精性脂肪肝炎 (NASH) 的老鼠的肝炎和肠道损伤. 这项研究强调了益生菌对NASH治疗的肠肝轴益处.
科学领域:
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
- 微生物学 微生物学
背景情况:
- 非酒精性脂肪肝炎 (NASH) 涉及肝脏脂肪,炎症和纤维化,可能导致肝硬化和肝癌.
- 了解肠肝轴对于开发有效的NASH治疗非常重要.
研究的目的:
- 研究益生菌对NASH的治疗作用,特别是二进制细菌细菌对NASH的治疗作用.
- 在大鼠模型中探索益生菌对肠肝轴的调节.
主要方法:
- 一种高脂肪饮食诱导了Sprague-Dawley大鼠在8周内产生NASH.
- 鼠被分为对照组,模型组 (高脂肪饮食+载体) 和治疗组 (高脂肪饮食+二进制Bacillus subtilis).
- 分析了炎症和肠道屏障完整性的肝脏和大肠组织标志物.
主要成果:
- 高脂肪饮食诱导了严重的肝脏和大肠炎症,通过增加IL-6和TNF-α证明了这一点.
- 二进制细菌治疗降低了肝脏IL-6和TNF-α水平.
- 益生菌干预降低了乳头IL-17和恢复了奥克卢丁表达,表明炎症减少和改善了肠道屏障功能.
结论:
- 二进制细菌表现出一种有益的效果,减轻与NASH相关的肝炎.
- 益生菌补充剂通过肠肝轴对肠道健康和屏障完整性产生积极影响.
关键词:
非酒精性型肝炎的治疗方法更多相关视频
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
865
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.3K
相关概念视频
Mucosal Barrier of the Stomach
717
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
717
Surface Membrane Barriers
1.2K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.2K
Drugs for Treatment of Ulcerative Colitis in IBD
175
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
175
Chronic Bowel Disorders: Introduction
489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
